Company overview
Basecamp Research develops AI foundation models like EDEN, trained on BaseData™, the world's largest evolutionary metagenomics dataset with over 9.8 billion protein sequences from diverse global environments. The company enables discovery of novel proteins, enzymes, and gene insertion tools for therapeutics in cancer and genetic diseases, as well as sustainable technologies. Partnerships with organizations in 28+ countries support biodiscovery and AI-powered design of programmable biological systems.
Basecamp Research — Beyond Known Biology is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents partner serving United States & Americas. Core focus areas include basecamp research, ai biology, protein design, metagenomics, gene therapy, eden models.
Industry categories: Life Science Reagents. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://basecamp-research.com
- Categories
- Life Science Reagents
- Markets served
- United States & Americas
- Keywords
- basecamp research, ai biology, protein design, metagenomics, gene therapy, eden models, basedata, biodiscovery
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What AI models and datasets does Basecamp Research offer for biology?
- Basecamp Research offers EDEN foundation models and aiPGI™ for programmable gene insertion, trained on BaseData™, the largest dataset with 9.8 billion protein sequences from global metagenomics.
- What therapeutic capabilities does Basecamp Research provide?
- They design novel proteins and enzymes for cell and gene therapies targeting cancer and genetic diseases, using AI to enable precise, programmable insertions and treatments.
- What are Basecamp Research's global partnerships and data sourcing?
- Basecamp Research partners with 152+ organizations in 28+ countries for ethically-sourced metagenomic data from extreme environments, supporting the Trillion Gene Atlas with 100,000 samples.
Related editorial coverage
- FDA CBER Patient Listening Meeting on Gene Therapy Safety: Patient and Care Partner Perspectives
- Sensorion pivots to SENS-601 after Regeneron’s OTOF hearing loss advance
- $2M Gene Therapy Cures Need a Financing Model
- Gene Therapy FDA Approval for Rare Disease: Updated List and Analysis
- Exclusive: FDA issues industry-friendly gene therapy guidance: What BD teams need to know
- FDA Issues June 2026 Guidance: Gene Therapy, Payor Comms, and CMC Flexibilities
Explore lab tools and QA/QC resources for R&D teams.
